KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Payables (2016 - 2025)

Evolent Health (EVH) has 10 years of Payables data on record, last reported at $77.3 million in Q3 2025.

  • For Q3 2025, Payables changed N/A year-over-year to $77.3 million; the TTM value through Sep 2025 reached $77.3 million, changed N/A, while the annual FY2024 figure was $267.5 million, 454.43% up from the prior year.
  • Payables reached $77.3 million in Q3 2025 per EVH's latest filing, down from $172.1 million in the prior quarter.
  • Across five years, Payables topped out at $267.5 million in Q4 2024 and bottomed at $39.0 million in Q2 2024.
  • Average Payables over 5 years is $97.8 million, with a median of $77.3 million recorded in 2025.
  • Peak YoY movement for Payables: tumbled 40.5% in 2022, then soared 454.43% in 2024.
  • A 5-year view of Payables shows it stood at $96.1 million in 2021, then crashed by 40.5% to $57.2 million in 2022, then decreased by 15.62% to $48.2 million in 2023, then skyrocketed by 454.43% to $267.5 million in 2024, then plummeted by 71.1% to $77.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $77.3 million in Q3 2025, $172.1 million in Q2 2025, and $171.8 million in Q1 2025.